HPV Vaccine Nearly Eliminates Cervical Cancer Deaths in Women

A landmark study published by Cancer Research UK indicates that the HPV vaccine has significantly decreased cervical cancer mortality among women under 30 in England. The research, led by Professor Peter Sasieni from Queen Mary University of London, analyzed national cancer mortality data and found that women vaccinated against HPV, particularly those who received the vaccine at ages 12-13, have an almost zero risk of dying from cervical cancer by age 30.

The study noted a 63% lower risk of death from cervical cancer among women aged 30-34 who were vaccinated compared to their unvaccinated counterparts. The HPV vaccine, introduced in England in 2008, is estimated to have prevented nearly 200 young women from dying from cervical cancer.

Health experts express concern over declining vaccination rates, emphasizing the need for strategies to achieve 90% vaccination coverage among girls by age 15 by 2030 to eliminate cervical cancer by 2040.